The National  Memo Logo

Smart. Sharp. Funny. Fearless.

Monday, December 09, 2019 {{ new Date().getDay() }}

New York (AFP) – Pharmaceutical giant Pfizer Tuesday announced that it settled patent litigation against Teva Pharmaceuticals over the sale of a generic version of blockbuster drug Viagra in the United States.

The settlement means Israel-based Teva “will be allowed to launch a generic version of Viagra in the U.S. on December 11, 2017 or earlier under certain circumstances,” Pfizer said in a statement.

“Teva will pay Pfizer a royalty for a license to produce its generic version,” Pfizer said.

Other terms of the agreement were confidential.

Patents for Viagra, which treats erectile dysfunction, expire in April 2020, Pfizer said.

In June 2010, Pfizer lost its patent in Brazil to exclusively sell the drug. Pfizer’s patent for Viagra has also expired in Europe and Japan.

The U.S. Food and Drug Administration has granted tentative approval for Teva’s generic version of Viagra, said Teva, which is the world’s biggest generic drug maker.

Photo: Waleed Alzuhair via Flickr

Start your day with National Memo Newsletter

Know first.

The opinions that matter. Delivered to your inbox every morning

Trump mob storming the Capitol on Jan. 6, 2021

Reprinted with permission from Alternet

Some of the January 6 rioters who are facing federal criminal charges are now saying, as part of their defense, that they were misled, brainwashed or unfairly manipulated by then-President Donald Trump, MAGA media and/or the QAnon cult. And one of the rioters who is using that type of defense is QAnon supporter Doug Jensen, who is saying that he was a "victim" of false information from the far-right conspiracy movement.

Keep reading... Show less

Close